Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
492 studies found for:    "Pharyngeal Neoplasms"
Show Display Options
Rank Status Study
1 Unknown  Study of Biomarker From Blood and Tissue of Head and Neck Carcinoma
Conditions: Laryngeal Neoplasms;   Pharyngeal Neoplasms
Intervention:
2 Unknown  Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy
Conditions: Pharyngeal Neoplasms;   Laryngeal Neoplasms;   Carcinoma
Interventions: Device: prothesis voice;   Procedure: total laryngectomy
3 Terminated Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Neoplasms;   Laryngeal Neoplasms;   Mouth Neoplasms;   Pharyngeal Neoplasms
Interventions: Drug: cetuximab;   Drug: cisplatin (associated to radiotherapy)
4 Recruiting Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal Cancer
Condition: Recurrent Pharyngeal Cancer
Interventions: Device: Cryosurgery;   Biological: NK immunotherapy
5 Completed
Has Results
Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer;   Pharynx Cancer
Interventions: Radiation: Chemoradiotherapy;   Drug: Cisplatin;   Drug: Bevacizumab;   Drug: Erlotinib
6 Recruiting Pilot Study to Improve Therapeutic Outcomes for Dysphagia After Radiation Therapy
Conditions: Dysphagia;   Oral Pharyngeal Cancer
Intervention: Device: Iowa Oral Performance Instrument
7 Completed Ultrasound Evaluation of Tongue Movements in Speech and Swallowing
Conditions: Otorhinolaryngologic Disease;   Otorhinolaryngologic Neoplasm;   Pharyngeal Neoplasm;   Polymyositis;   Speech Disorder
Intervention:
8 Completed Resistance Training and Physical Functioning in Head and Neck Cancer Patients
Conditions: Head and Neck Cancer;   Pharyngeal Cancer;   Laryngeal Cancer
Interventions: Behavioral: Nutrition Counseling;   Behavioral: Resistance Training and Nutrition Counseling
9 Completed Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer
Conditions: Head and Neck Cancer;   Pharyngeal Cancer;   Laryngeal Cancer
Interventions: Behavioral: Nutrition Counseling;   Behavioral: Resistance Training
10 Terminated Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population
Conditions: Pharynx Cancer;   Larynx Cancer;   Oral Cavity Cancer;   Oesophageal Cancer
Intervention: Procedure: Screening by head and neck clinical examination with a fiberoptic nasolaryngoscopy and an oesopharyngeal brush biopsy annually during 3 years
11 Completed
Has Results
Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
Conditions: Cancer of the Pharynx;   Cancer of the Larynx;   Cancer of the Neck;   Paranasal Sinus Neoplasms;   Cancer of the Head
Intervention: Drug: erlotinib + celecoxib
12 Unknown  Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
Conditions: Cancer of the Pharynx;   Cancer of the Larynx;   Cancer of the Nasal Cavity;   Paranasal Sinus Neoplasms;   Cancer of the Oral Cavity
Interventions: Drug: docetaxel;   Drug: cisplatin;   Drug: hydroxyurea;   Drug: fluorouracil;   Procedure: chemotherapy;   Procedure: radiotherapy
13 Active, not recruiting Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer
Conditions: Larynx Cancer;   Lip Cancer;   Oral Cavity Cancer;   Pharyngeal Cancer;   Oropharyngeal Cancer
Intervention:
14 Completed Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer
Conditions: Carcinoma, Squamous;   Head and Neck Cancer;   Oral Cancer;   Laryngeal Cancer;   Pharyngeal Cancer
Interventions: Drug: Bortezomib (Velcade, PS-341);   Drug: Cetuximab;   Drug: Cisplatin;   Procedure: Radiation Therapy
15 Recruiting Patient Evaluation for Head and Neck Surgery Branch Studies
Conditions: Head and Neck Neoplasms;   Pharyngeal Cancer;   Oral Cancer;   Carcinoma, Squamous Cell;   Laryngeal Cancer
Intervention:
16 Recruiting Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer
Conditions: Head and Neck Cancer;   Carcinoma, Squamous Cell;   Neoplasms, Oral;   Neoplasms, Pharyngeal
Interventions: Radiation: Intensity Modulated Radiation Therapy;   Drug: chemotherapy
17 Completed Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer;   Cancer of the Pharynx;   Cancer of the Larynx;   Nose Neoplasms;   Paranasal Sinus Neoplasms;   Cancer of the Oral Cavity
Interventions: Drug: cetuximab;   Drug: hydroxyurea;   Drug: fluorouracil;   Procedure: chemotherapy;   Procedure: radiotherapy
18 Recruiting uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer
Conditions: Oral Cancer;   Oropharyngeal Cancer;   Neoplasms;   Head and Neck Neoplasms;   Cancer of Mouth;   Neoplasms by Site
Intervention: Other: 68Ga-NOTA-AE105 PET/CT
19 Not yet recruiting A Study to Evaluate the Safety and Efficacy of Using the Combination Treatment of SHR-1210, Gemcitabine and Cis-platinum by Recurrent and Metastatic NPC Subjects
Condition: Nasopharyngeal Carcinoma
Interventions: Biological: SHR-1210;   Drug: Gemcitabine;   Drug: cis-platinum
20 Not yet recruiting Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Other: adverse events using patient-reported outcomes version of common terminology criteria for adverse events (PRO-CTCAE) questionaire;   Other: do not report adverse events through patient-reported outcomes version of common terminology criteria for adverse events (PRO-CTCAE) questionaire

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.